BCD274CD274,sintilimab:

Xian Zhang1, Liye Xu1, Evenki Pan2

  • 1Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, P.R. China.

Oncology letters
|May 13, 2024
PubMed
概括

耐火性扩散性大B细胞淋巴瘤 (DLBCL) 患者可能从向治疗中受益. 下一代测序发现了CD274放大,导致用sintilimab成功治疗.